DOD Biotech Public Co., Ltd.(TH:DOD)
฿0.71+0.03 (+4.41%)
TH:DOD
DOD Biotech Public Co., Ltd. financials statements
฿0.71
At close:+0.03 (+4.41%)
DOD Biotech Public Co., Ltd. (DOD) Ratios
DOD Biotech Public Co., Ltd. Ratios
TH:DOD's free cash flow for Q2 2026 was ฿17.50M. For the 2026 fiscal year, TH:DOD's free cash flow was decreased by ฿-2.20M and operating cash flow was ฿19.70M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 4.28 | 1.68 | 1.32 | 0.65 | 2.42 |
| Quick Ratio | 3.32 | 1.34 | 0.78 | 0.33 | 1.98 |
| Cash Ratio | 1.11 | 0.61 | 0.24 | 0.10 | 0.62 |
| Solvency Ratio | 0.51 | -0.25 | 0.21 | -0.71 | 0.82 |
| Operating Cash Flow Ratio | 0.79 | 0.10 | 0.08 | -0.43 | 0.56 |
| Short-Term Operating Cash Flow Coverage | 6.91 | 0.77 | 0.20 | -0.78 | 1.37 |
| Net Current Asset Value | ฿ 297.21M | ฿ 222.15M | ฿ -5.62M | ฿ -200.16M | ฿ 261.30M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.06 | 0.04 | 0.12 | 0.18 | 0.11 |
| Debt-to-Equity Ratio | 0.07 | 0.05 | 0.16 | 0.26 | 0.14 |
| Debt-to-Capital Ratio | 0.07 | 0.05 | 0.14 | 0.21 | 0.13 |
| Long-Term Debt-to-Capital Ratio | 0.06 | 0.00 | 0.00 | 0.00 | 0.01 |
| Financial Leverage Ratio | 1.20 | 1.43 | 1.38 | 1.46 | 1.27 |
| Debt Service Coverage Ratio | 4.77 | 1.88 | 0.85 | -1.56 | 2.73 |
| Interest Coverage Ratio | 9.46 | 11.65 | 6.88 | -1.59 | 40.44 |
| Debt to Market Cap | 0.10 | 0.06 | 0.07 | 0.10 | 0.03 |
| Interest Debt Per Share | 0.16 | 0.11 | 0.43 | 0.57 | 0.46 |
| Net Debt to EBITDA | -0.84 | -1.69 | 0.77 | -0.56 | 0.06 |
| Profitability Margins | |||||
| Gross Profit Margin | 34.49% | 32.04% | 40.08% | 26.16% | 42.81% |
| EBIT Margin | 4.45% | 6.85% | 8.43% | -77.66% | 26.77% |
| EBITDA Margin | 11.51% | 16.25% | 19.26% | -65.65% | 33.37% |
| Operating Profit Margin | 4.45% | 6.74% | 8.39% | -2.10% | 26.74% |
| Pretax Profit Margin | 7.13% | 6.27% | 7.21% | -78.98% | 26.11% |
| Net Profit Margin | 9.78% | -24.69% | 1.06% | -64.25% | 22.96% |
| Continuous Operations Profit Margin | 8.23% | 4.21% | 3.07% | -64.25% | 22.96% |
| Net Income Per EBT | 137.15% | -393.49% | 14.70% | 81.35% | 87.94% |
| EBT Per EBIT | 160.39% | 93.10% | 85.92% | 3764.42% | 97.62% |
| Return on Assets (ROA) | 5.16% | -12.39% | 0.49% | -26.73% | 14.33% |
| Return on Equity (ROE) | 6.22% | -17.73% | 0.68% | -38.90% | 18.20% |
| Return on Capital Employed (ROCE) | 2.61% | 4.73% | 4.84% | -1.14% | 19.85% |
| Return on Invested Capital (ROIC) | 2.58% | 3.02% | 1.88% | -0.79% | 16.15% |
| Return on Tangible Assets | 5.34% | -12.82% | 0.51% | -26.85% | 14.38% |
| Earnings Yield | 8.17% | -21.31% | 0.47% | -19.26% | 5.06% |
| Efficiency Ratios | |||||
| Receivables Turnover | 8.44 | 15.33 | 6.08 | 9.38 | 3.01 |
| Payables Turnover | 9.34 | 11.18 | 10.57 | 5.99 | 6.24 |
| Inventory Turnover | 3.56 | 3.46 | 2.70 | 4.05 | 5.12 |
| Fixed Asset Turnover | 1.20 | 1.26 | 0.74 | 0.55 | 1.05 |
| Asset Turnover | 0.53 | 0.50 | 0.47 | 0.42 | 0.62 |
| Working Capital Turnover Ratio | 1.93 | 3.80 | -76.10 | 4.13 | 3.55 |
| Cash Conversion Cycle | 106.59 | 96.75 | 160.60 | 68.21 | 134.12 |
| Days of Sales Outstanding | 43.26 | 23.81 | 60.04 | 38.93 | 121.31 |
| Days of Inventory Outstanding | 102.40 | 105.59 | 135.10 | 90.20 | 71.32 |
| Days of Payables Outstanding | 39.08 | 32.65 | 34.53 | 60.92 | 58.51 |
| Operating Cycle | 145.67 | 129.40 | 195.14 | 129.13 | 192.63 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 0.20 | 0.08 | 0.06 | -0.32 | 0.35 |
| Free Cash Flow Per Share | 0.09 | 0.03 | 0.01 | -0.47 | -0.09 |
| Dividend Paid and CapEx Coverage Ratio | 1.87 | 1.55 | 1.26 | -2.07 | 0.79 |
| Capital Expenditure Coverage Ratio | 1.87 | 1.55 | 1.26 | -2.07 | 0.79 |
| Operating Cash Flow Coverage Ratio | 1.30 | 0.76 | 0.14 | -0.57 | 0.79 |
| Operating Cash Flow to Sales Ratio | 0.15 | 0.05 | 0.03 | -0.24 | 0.14 |
| Free Cash Flow Yield | 5.82% | 1.65% | 0.31% | -10.83% | -0.82% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 12.46 | -4.74 | 211.43 | -5.19 | 19.65 |
| Price-to-Sales (P/S) Ratio | 1.20 | 1.16 | 2.24 | 3.34 | 4.53 |
| Price-to-Book (P/B) Ratio | 0.76 | 0.83 | 1.43 | 2.02 | 3.59 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 17.20 | 60.74 | 321.17 | -9.24 | -121.35 |
| Price-to-Operating Cash Flow Ratio | 7.99 | 21.48 | 66.54 | -13.71 | 31.74 |
| Price-to-Earnings Growth (PEG) Ratio | -0.09 | 0.00 | -2.07 | 0.02 | 0.29 |
| Enterprise Value Multiple | 9.57 | 5.44 | 12.39 | -5.65 | 13.65 |
| Enterprise Value | 670.79M | 570.66M | 1.62B | 1.99B | 4.62B |
| EV to EBITDA | 9.57 | 5.44 | 12.39 | -5.65 | 13.65 |
| EV to Sales | 1.10 | 0.88 | 2.39 | 3.71 | 4.55 |
| EV to Free Cash Flow | 15.81 | 46.36 | 342.49 | -10.26 | -121.92 |
| EV to Operating Cash Flow | 7.35 | 16.40 | 70.96 | -15.23 | 31.89 |
| Tangible Book Value Per Share | 2.03 | 1.88 | 2.51 | 2.16 | 3.06 |
| Shareholders’ Equity Per Share | 2.13 | 2.00 | 2.58 | 2.16 | 3.12 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -0.15 | 0.33 | 0.57 | 0.19 | 0.12 |
| Revenue Per Share | 1.35 | 1.43 | 1.65 | 1.31 | 2.47 |
| Net Income Per Share | 0.13 | -0.35 | 0.02 | -0.84 | 0.57 |
| Tax Burden | 1.37 | -3.93 | 0.15 | 0.81 | 0.88 |
| Interest Burden | 1.60 | 0.92 | 0.86 | 1.02 | 0.98 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.30 | 0.32 | 0.29 | 0.30 | 0.12 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 1.91 | -0.19 | 1.13 | 0.27 | 3.52 |
Currency in THB
